Articles by Jeff Odum - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jeff Odum

Final Word: The Case for Flexible Manufacturing Capacity

We need to bridge the gap between vaccine R&D and our limited commercial manufacturing capacity
Aug 1, 2007

The mounting threats of pandemic influenza, bioterrorism, and emerging infectious diseases continue to be the focus of research programs and funding initiatives, not only within governmental agencies, but also universities, private research firms, and commercial manufacturing entities. With all of these efforts, however, the question of manufacturing capacity and the ability to respond to pandemic and emerging threats continues to be a major concern.

ADVERTISEMENT

ADVERTISEMENT

Click here